BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31552488)

  • 1. A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.
    Liu L; Song X; Li X; Xue L; Ding S; Niu L; Xie L; Song X
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2713-2723. PubMed ID: 31552488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEP linc-GTF2H2-1, RP3-466P17.2, and lnc-ST8SIA4-12 as novel biomarkers for lung cancer diagnosis and progression prediction.
    Li X; Liu L; Song X; Wang K; Niu L; Xie L; Song X
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1609-1622. PubMed ID: 33792796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients.
    Li J; Li S; Liu Q; Li Y; Zhou Q; Yuan S; Wang Z
    Asian Pac J Cancer Prev; 2011; 12(12):3201-6. PubMed ID: 22471454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-educated platelet SNORD55 as a potential biomarker for the early diagnosis of non-small cell lung cancer.
    Dong X; Song X; Ding S; Yu M; Shang X; Wang K; Chang M; Xie L; Song X
    Thorac Cancer; 2021 Mar; 12(5):659-666. PubMed ID: 33474827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
    Du ZY; Shi MH; Ji CH; Yu Y
    Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer.
    Kammer MN; Kussrow AK; Webster RL; Chen H; Hoeksema M; Christenson R; Massion PP; Bornhop DJ
    ACS Comb Sci; 2019 Jun; 21(6):465-472. PubMed ID: 31022347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylated Alpha-1-acid glycoprotein 1 as a potential lung cancer serum biomarker.
    Ayyub A; Saleem M; Fatima I; Tariq A; Hashmi N; Musharraf SG
    Int J Biochem Cell Biol; 2016 Jan; 70():68-75. PubMed ID: 26563422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Significance of ACIN1 mRNA in Platelets of Lung Cancer].
    Xue L; Xie L; Song X; Song X
    Zhongguo Fei Ai Za Zhi; 2018 Sep; 21(9):677-681. PubMed ID: 30201066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
    Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
    Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular approach to diagnosis in lung cancer.
    Moore DA; Le Quesne JP
    Br J Hosp Med (Lond); 2015 May; 76(5):C74-6. PubMed ID: 25959953
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.
    Grinberg-Rashi H; Ofek E; Perelman M; Skarda J; Yaron P; Hajdúch M; Jacob-Hirsch J; Amariglio N; Krupsky M; Simansky DA; Ram Z; Pfeffer R; Galernter I; Steinberg DM; Ben-Dov I; Rechavi G; Izraeli S
    Clin Cancer Res; 2009 Mar; 15(5):1755-61. PubMed ID: 19190132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.
    Zhu Y; Wei Y; Zhang R; Dong X; Shen S; Zhao Y; Bai J; Albanes D; Caporaso NE; Landi MT; Zhu B; Chanock SJ; Gu F; Lam S; Tsao MS; Shepherd FA; Tardon A; Fernández-Somoano A; Fernandez-Tardon G; Chen C; Barnett MJ; Doherty J; Bojesen SE; Johansson M; Brennan P; McKay JD; Carreras-Torres R; Muley T; Risch A; Wichmann HE; Bickeboeller H; Rosenberger A; Rennert G; Saliba W; Arnold SM; Field JK; Davies MPA; Marcus MW; Wu X; Ye Y; Le Marchand L; Wilkens LR; Melander O; Manjer J; Brunnström H; Hung RJ; Liu G; Brhane Y; Kachuri L; Andrew AS; Duell EJ; Kiemeney LA; van der Heijden EH; Haugen A; Zienolddiny S; Skaug V; Grankvist K; Johansson M; Woll PJ; Cox A; Taylor F; Teare DM; Lazarus P; Schabath MB; Aldrich MC; Houlston RS; McLaughlin J; Stevens VL; Shen H; Hu Z; Dai J; Amos CI; Han Y; Zhu D; Goodman GE; Chen F; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):935-942. PubMed ID: 30700444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
    Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
    J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.